tailieunhanh - Báo cáo y học: "Correction: The PTPN22 1858C/T polymorphism is associated with anti-cyclic citrullinated peptide antibody-positive early rheumatoid arthritis in northern Sweden"

Tuyển tập các báo cáo nghiên cứu về y học được đăng trên tạp chí y học General Psychiatry cung cấp cho các bạn kiến thức về ngành y đề tài: Correction: The PTPN22 1858C/T polymorphism is associated with anti-cyclic citrullinated peptide antibody-positive early rheumatoid arthritis in northern Sweden. | Available online http content 9 5 403 Correction Correction The PTPN22 1858C T polymorphism is associated with anti-cyclic citrullinated peptide antibody-positive early rheumatoid arthritis in northern Sweden Heidi Kokkonen1 Martin Johansson1 Lena Innala1 Erik Jidell2 and Solbritt Rantapăă-Dahlqvist1 1 Department of Rheumatology University Hospital SE-901 85 Umea Sweden 2Department of Transfusion Medicine University Hospital SE-901 85 Umea Sweden Corresponding author Solbritt Rantapăă-Dahlqvist Published 25 October 2007 This article is online at http content 9 5 403 2007 BioMed Central Ltd Arthritis Research Therapy 2007 9 403 doi ar2312 See related research article by Kokkonen et al. http content 9 3 R56 After publication of our recent article 1 we noticed an error in Table 6 Relative risk for developing rheumatoid arthritis in patients stratified for anti-cyclic citrullinated peptide anti-CCP antibodies . Under the heading of Anti-CCP antibody-positive the first line should read HLA-shared epitope-negative and the second line should read HLA-shared epitope-positive . Similarly under the heading Anti-CCP antibody-negative the first line should read HLA-shared epitope-negative and the second line should read HLA-shared epitope-positive . The correct table is given here as Table 1 a corrected version of Table 6 1 . Reference 1. Kokkonen H Johansson M Innala L Jidell E Rantapăă-Dahlqvist S The PTPN22 1858C T polymorphism is associated with anti-cyclic citrullinated peptide antibody-positive early rheumatoid arthritis in northern Sweden. Arthritis Res Ther 2007 9 R56. Table 1 Relative risk for developing rheumatoid arthritis in patients stratified for anti-cyclic citrullinated peptide anti-CCP antibodies Nonsmoking Smoking Cases controls Relative risk 95 confidence interval Cases controls Relative risk confidence interval Anti-CCP antibody-positive .